BioSpace News Archive

Career Advice

What Astronaut Peggy Whitson Can Teach Us About Rejection in the Workplace

Peggy Whitson has spent 665 days in space, more than any other US astronaut and more than any other female astronaut in the world. You don’t associate Peggy Whitson with failure. But...

March 15, 2018
·
5 min read
Business

Ionis Pharmaceuticals Partners With Akcea Therapeutics in a Potential $1.7 Billion Deal

Ionis Pharmaceuticals has signed a worldwide license deal to Akcea Therapeutics for inotersen and AKCEA-TTR-LRx in a deal that could hit $1.7 billion.

March 15, 2018
·
3 min read
·
Mark Terry
Career Advice

Most important things to do before your next video job interview

Online video interviews are becoming increasingly common as remote employment increases and globalization changes the labor market.So what are the most important things you need to know about video interviewing?

March 15, 2018
·
7 min read
Drug Development

FDA Slaps Clinical Hold on Solid Bioscience DMD Gene Therapy Program

A U.S. Food and Drug Administration announced their decision to slap a clinical hold on Solid Biosciences Inc.’s experimental gene therapy treatment for Duchenne muscular dystrophy.

March 15, 2018
·
3 min read
·
Alex Keown
Deals

Consolidation Could Be Coming to Pharma Industry

The Wall Street Journal speculated today that it won’t be long before drug manufacturers start consolidating in order to improve their bottom lines.

March 15, 2018
·
3 min read
·
Alex Keown
Deals

Is Celgene Considering Going Private?

Celgene has a deep pipeline and a $69 billion market cap, but it could consider going private in 2019 via a leveraged buyout.

March 15, 2018
·
3 min read
·
Mark Terry
Drug Development

Alexion’s Prospects Rise with Positive Phase III Trial Data

Alexion Pharmaceuticals announced positive results from its pivotal Phase III clinical trial for a life-threatening blood disease.

March 15, 2018
·
2 min read
·
Mark Terry
Biotech Bay

IDEAYA Biosciences Nabs $94 Million

IDEAYA Biosciences has raised $94 million in Series B funding to drive multiple clinical studies in 2019.

March 15, 2018
·
2 min read
·
Alex Keown
FDA

Eli Lilly Gets Another Shot at FDA Approval for RA Drug

On April 23, the FDA’s arthritis advisory committee will take another look at Eli Lilly’s re-submission for their moderate-to-severe rheumatoid arthritis drug.

March 15, 2018
·
2 min read
·
Mark Terry
Policy

Sinovac Sets the Record Straight Regarding False Statements by Unauthorized Third Parties

Leading provider of biopharmaceutical products in China, today responded to public statements made by other parties falsely claiming to control the Company, including a press release falsely purporting to come from Sinovac itself.

March 15, 2018
·
4 min read